No evidence, yet ADT often used in localized prostate cancer (Medscape, 16 July 2014)

16 Jul 2014


A population-based cohort study of more than 60,000 men published in JAMA Internal Medicine investigated whether androgen-deprivation therapy benefits older patients suffering from localised prostate cancer.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story